Rothschild Investment LLC Catalyst Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 180 shares of CPRX stock, worth $3,972. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 120
50.0%
Holding current value
$3,972
Previous $2.5 Million
74.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$413 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$187 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$122 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$75.5 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$69.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.27B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...